# Caleb Bell

> Caleb Bell is a Series A investor at Corundum Systems Biology backing Biopharma and Therapeutics. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Corundum Systems Biology](https://shizune.co/investors/profile/corundum-systems-biology)
- Location: San Francisco, United States
- Total investments: 1
- Last investment: Sep 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/caleb3/

Caleb Bell is a Series A investor at Corundum Systems Biology in San Francisco focused on Biopharma and Therapeutics. Caleb received a B.S. Degree in Biochemistry and Molecular Biology from Penn State University and a Ph.D. in Biophysical Chemistry from Stanford University. He completed the Stanford Graduate School of Business Ignite Program. Caleb's research interests include anaerobic microbiology, biological magnetic phenomena and various spectroscopicmethods for biochemical and biomedical research. He founded two companies prior to Bell Biosystems, Inc., and served as CEO of one for six years.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Elevian | Elevian’s founders discovered circulating blood factors that regulate aging, including GDF11, which broadly stimulate regeneration of brain, heart, pancreas, muscle, and other tissues. Elevian is developing therapeutics that stimulate regenerative capacity, to treat and prevent age-related disease. | $40M | Series A | Sep 16, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Bold Capital Partners](https://shizune.co/investors/profile/bold-capital) — VC Fund, 1 deal together
- [Kuelbs Family Office](https://shizune.co/investors/profile/kuelbs-family-office) — VC Fund, 1 deal together
- [Leslie Ventures](https://shizune.co/investors/profile/leslie-ventures) — VC Fund, 1 deal together

## About Corundum Systems Biology

VC Fund

Corundum Systems Biology develops new businesses in the field of microbiome.

1 contacts available at Corundum Systems Biology.

| Name | Title | Profile |
| --- | --- | --- |
| Caleb Bell | Venture Partner | https://shizune.co/investors/profile/caleb-bell-iii |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Caleb Bell invest in?

Caleb Bell invests primarily in Biopharma, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Caleb Bell last invest?

The most recent investment recorded for Caleb Bell closed in Sep 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co